Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Capital Expenditures (2020 - 2023)

Privia Health (PRVA) has 4 years of Capital Expenditures data on record, last reported at $23000.0 in Q4 2023.

  • For Q4 2023, Capital Expenditures rose 53.33% year-over-year to $23000.0; the TTM value through Dec 2023 reached $113000.0, up 8.65%, while the annual FY2023 figure was $113000.0, 8.65% up from the prior year.
  • Capital Expenditures reached $23000.0 in Q4 2023 per PRVA's latest filing, up from $18000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $366000.0 in Q2 2020 and bottomed at $1000.0 in Q3 2020.
  • Average Capital Expenditures over 4 years is $88000.0, with a median of $34000.0 recorded in 2022.
  • Peak YoY movement for Capital Expenditures: soared 19600.0% in 2021, then plummeted 91.88% in 2022.
  • A 4-year view of Capital Expenditures shows it stood at $1000.0 in 2020, then surged by 15000.0% to $151000.0 in 2021, then plummeted by 90.07% to $15000.0 in 2022, then soared by 53.33% to $23000.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $23000.0 in Q4 2023, $18000.0 in Q3 2023, and $72000.0 in Q2 2023.